Ankasa Regenerative Therapeutics

About:

Ankasa Regenerative Therapeutics develops a technology to improve tissue healing by stem cell reactivation process.

Website: https://ankasaregenerativetherapeutics.com/

Top Investors: Correlation Ventures, Avalon Ventures, Heraeus

Description:

Ankasa Regenerative Therapeutics is a biopharmaceutical company developing strategies to improve tissue healing by exploiting the potential of stem cell reactivation. The company is developing proprietary formulations of a potent WNT stem cell activator with the potential to accelerate tissue healing in a broad range of degenerative conditions affecting bone, cartilage, skin, muscle, vasculature, and the central nervous system. Its proprietary approach has demonstrated superiority for bone reformation over existing standards of care in various preclinical models. Ankasa Regenerative Therapeutics was established in 2014 and is headquartered in La Jolla, California.

Total Funding Amount:

$14.5M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2014-01-01

Founders:

Jill Helms, Sanford J. Madigan

Number of Employees:

1001-5000

Last Funding Date:

2020-10-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai